产品名称
4,4,4-三氟-1-苯基-1,3-丁二酮, 99%
InChI key
VVXLFFIFNVKFBD-UHFFFAOYSA-N
InChI
1S/C10H7F3O2/c11-10(12,13)9(15)6-8(14)7-4-2-1-3-5-7/h1-5H,6H2
SMILES string
FC(F)(F)C(=O)CC(=O)c1ccccc1
assay
99%
form
solid
bp
224 °C (lit.)
mp
38-40 °C (lit.)
solubility
95% ethanol: soluble 25 mg/mL, clear, colorless to yellow
functional group
fluoro
ketone
phenyl
Quality Level
Application
4,4,4-三氟-1-苯基-1,3-丁二酮通过席夫碱缩合反应合成了一系列三氟甲基取代的 NNO 酮亚胺 。它还被用于混合配体螯合萃取三价镧系元素 和作为配体制备三元镧系元素 (Ln) 配合物 。
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
210.2 °F - closed cup
flash_point_c
99 °C - closed cup
Zexi Cai et al.
BMC genetics, 20(1), 15-15 (2019-01-31)
Genome-wide association studies (GWAS) have been successfully implemented in cattle research and breeding. However, moving from the associations to identify the causal variants and reveal underlying mechanisms have proven complicated. In dairy cattle populations, we face a challenge due to
M E Grobman et al.
Journal of veterinary internal medicine, 33(3), 1423-1433 (2019-04-11)
Megaesophagus (ME) carries a poor long-term prognosis in dogs. In people, lower esophageal sphincter (LES) achalasia is a rare cause of ME that may respond to targeted intervention. Dogs with lower esophageal sphincter achalasia-like syndrome (LES-AS) have been described recently
Leire Palencia-Madrid et al.
Genes, 11(6) (2020-07-02)
The study of DNA to predict externally visible characteristics (EVCs) and the biogeographical ancestry (BGA) from unknown samples is gaining relevance in forensic genetics. Technical developments in Massively Parallel Sequencing (MPS) enable the simultaneous analysis of hundreds of DNA markers
Makoto Utsunomiya et al.
JACC. Cardiovascular interventions, 10(2), 188-194 (2017-01-21)
This study aimed to assess the optimal angiographic endpoint of endovascular therapy (EVT) for wound healing. Several reports have demonstrated acceptable patency and limb salvage rates following infrapopliteal interventions for the treatment of critical limb ischemia (CLI). However, the optimal angiographic
Jean-Jacques Body et al.
Journal of bone oncology, 14, 100212-100212 (2019-01-11)
Bone metastases (BMs) are common in patients with prostate cancer and can lead to skeletal-related events (SREs), which are associated with increased pain and reduced quality of life (QoL). Bone-targeted agents (BTAs), such as zoledronic acid and denosumab, reduce the
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持